105 related articles for article (PubMed ID: 15187817)
1. Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up.
Fisman EZ; Motro M; Tenenbaum A; Leor J; Boyko V; Mandelzweig L; Sherer Y; Adler Y; Behar S
Eur J Cardiovasc Prev Rehabil; 2004 Apr; 11(2):135-43. PubMed ID: 15187817
[TBL] [Abstract][Full Text] [Related]
2. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
[TBL] [Abstract][Full Text] [Related]
3. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study.
Arcavi L; Behar S; Caspi A; Reshef N; Boyko V; Knobler H
Am Heart J; 2004 Feb; 147(2):239-45. PubMed ID: 14760320
[TBL] [Abstract][Full Text] [Related]
4. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
[TBL] [Abstract][Full Text] [Related]
5. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
[TBL] [Abstract][Full Text] [Related]
6. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis.
Fisman EZ; Motro M; Tenenbaum A; Boyko V; Mandelzweig L; Behar S
Am Heart J; 2001 Mar; 141(3):485-90. PubMed ID: 11231448
[TBL] [Abstract][Full Text] [Related]
7. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
[TBL] [Abstract][Full Text] [Related]
8. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
Arbel Y; Klempfner R; Erez A; Goldenberg I; Benzekry S; Shlomo N; Fisman EZ; Tenenbaum A;
Cardiovasc Diabetol; 2016 Jan; 15():11. PubMed ID: 26794137
[TBL] [Abstract][Full Text] [Related]
9. Long term prognostic utility of coronary CT angiography in patients with no modifiable coronary artery disease risk factors: Results from the 5 year follow-up of the CONFIRM International Multicenter Registry.
Cheruvu C; Precious B; Naoum C; Blanke P; Ahmadi A; Soon J; Arepalli C; Gransar H; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Al-Mallah MH; Cademartiri F; Chinnaiyan K; Rubinshtein R; Marquez H; DeLago A; Villines TC; Hadamitzky M; Hausleiter J; Shaw LJ; Kaufmann PA; Cury RC; Feuchtner G; Kim YJ; Maffei E; Raff G; Pontone G; Andreini D; Chang HJ; Min JK; Leipsic J
J Cardiovasc Comput Tomogr; 2016; 10(1):22-7. PubMed ID: 26719237
[TBL] [Abstract][Full Text] [Related]
10. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up.
Hadaegh F; Ehteshami-Afshar S; Hajebrahimi MA; Hajsheikholeslami F; Azizi F
Int J Cardiol; 2015 Mar; 182():334-9. PubMed ID: 25585379
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
Vaidya D; Kelemen MD; Bittner V; Tardif JC; Thompson P; Ouyang P
J Womens Health (Larchmt); 2007 Mar; 16(2):228-34. PubMed ID: 17388739
[TBL] [Abstract][Full Text] [Related]
12. The Association of Body Mass Index and 20-Year All-Cause Mortality Among Patients With Stable Coronary Artery Disease.
Younis A; Younis A; Goldkorn R; Goldenberg I; Peled Y; Tzur B; Klempfner R
Heart Lung Circ; 2019 May; 28(5):719-726. PubMed ID: 29581037
[TBL] [Abstract][Full Text] [Related]
13. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Lenzen M; Ryden L; Ohrvik J; Bartnik M; Malmberg K; Scholte Op Reimer W; Simoons ML;
Eur Heart J; 2006 Dec; 27(24):2969-74. PubMed ID: 17090612
[TBL] [Abstract][Full Text] [Related]
14. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.
Muhlestein JB; Lappé DL; Lima JA; Rosen BD; May HT; Knight S; Bluemke DA; Towner SR; Le V; Bair TL; Vavere AL; Anderson JL
JAMA; 2014 Dec; 312(21):2234-43. PubMed ID: 25402757
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization.
Nusca A; Patti G; Marino F; Mangiacapra F; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2012 Sep; 80(3):377-84. PubMed ID: 21681905
[TBL] [Abstract][Full Text] [Related]
17. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
18. Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact.
Bauters C; Tricot O; Lemesle G; Meurice T; Hennebert O; Farnier M; Lamblin N
Arch Cardiovasc Dis; 2018 Nov; 111(11):634-643. PubMed ID: 29198936
[TBL] [Abstract][Full Text] [Related]
19. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease.
Min JK; Dunning A; Lin FY; Achenbach S; Al-Mallah M; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Cheng V; Chinnaiyan K; Chow BJ; Delago A; Hadamitzky M; Hausleiter J; Kaufmann P; Maffei E; Raff G; Shaw LJ; Villines T; Berman DS;
J Am Coll Cardiol; 2011 Aug; 58(8):849-60. PubMed ID: 21835321
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose.
Knobler H; Benderly M; Boyko V; Behar S; Matas Z; Rubinstein A; Raz I; Wainstein J
Eur J Endocrinol; 2006 Jan; 154(1):87-92. PubMed ID: 16381996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
